Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 3608 to 3657 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent germ cell-less. [source:refseq;acc:nm\_022471]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.877\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1805\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha-actinin 4 (non-muscle alpha-actinin 4) (f-actin cross linking protein). [source:swissprot;acc:o43707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.008\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.482\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01178\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent pre-b-cell leukemia transcription factor-3 (homeobox protein pbx3). [source:swissprot;acc:p40426]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1806\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha-actinin 1 (alpha-actinin cytoskeletal isoform) (non-muscle alpha-actinin 1) (f-actin cross linking protein). [source:swissprot;acc:p12814]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.009\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.482\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01178\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent hyporthetical protein mgc27169. [source:refseq;acc:nm\_176782]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 206.332\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 203.874\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1807\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein meis1. [source:swissprot;acc:o00470]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ral guanine nucleotide exchange factor ralgps1a. [source:refseq;acc:nm\_014636]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.102\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01175\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1808\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein meis2 (meis1-related protein 1). [source:swissprot;acc:o14770]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ral-a exchange factor ralgps2. [source:refseq;acc:nm\_152663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.102\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01175\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1809\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent bag-family molecular chaperone regulator-2. [source:swissprot;acc:o95816]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent stip1 homology and u-box containing protein 1; serologically defined colon cancer antigen 7; carboxy terminus of hsp70p-interacting protein; heat shock protein a binding protein 2 (c-terminal). [source:refseq;acc:nm\_005861]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.102\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01175\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1810\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent lon protease homolog, mitochondrial precursor (ec 3.4.21.-) (lon protease-like protein) (lonp) (lonhs). [source:swissprot;acc:p36776]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 223.214\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 225.827\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01171\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent pre-b-cell leukemia transcription factor-2 (homeobox protein pbx2) (g17 protein). [source:swissprot;acc:p40425]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1811\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent polypeptide n-acetylgalactosaminyltransferase 2; udp-galnac transferase 2. [source:refseq;acc:nm\_004481]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01168\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent pre-b-cell leukemia transcription factor 4. [source:refseq;acc:nm\_025245]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1812\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin c. [source:swissprot;acc:p24863]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.071\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.564\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01168\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein meis3 (meis1-related protein 2) (fragment). [source:swissprot;acc:q99687]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.458\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1813\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ral guanine nucleotide exchange factor ralgps1a. [source:refseq;acc:nm\_014636]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 211.102\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.451\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent similar to expressed sequence ai415388 (fragment). [source:sptrembl;acc:q8n428]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01168\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1814\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ral-a exchange factor ralgps2. [source:refseq;acc:nm\_152663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.102\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.451\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase pp1-gamma catalytic subunit (ec 3.1.3.16) (pp-1g). [source:swissprot;acc:p36873]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 122.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 123.727\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01167\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1815\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dpy-30-like protein. [source:swissprot;acc:q9c005]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 220.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01164\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent stip1 homology and u-box containing protein 1; serologically defined colon cancer antigen 7; carboxy terminus of hsp70p-interacting protein; heat shock protein a binding protein 2 (c-terminal). [source:refseq;acc:nm\_005861]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.102\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.451\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1816\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 187.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 190.028\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.446\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rab coupling protein; rab-interacting recycling protein; rab effector protein; rab11-family interacting protein 1. [source:refseq;acc:nm\_025151]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01164\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1817\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent f-actin capping protein alpha-1 subunit (capz alpha-1). [source:swissprot;acc:p52907]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.722\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.281\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.441\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent gamma-snap-associated factor 1; rab11-interacting protein. [source:refseq;acc:nm\_015470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01164\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1818\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cad protein [includes: glutamine-dependent carbamoyl-phosphate synthase (ec 6.3.5.5); aspartate carbamoyltransferase (ec 2.1.3.2); dihydroorotase (ec 3.5.2.3)]. [source:swissprot;acc:p27708]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.439\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neighbor of cox4. [source:swissprot;acc:o43402]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01164\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1819\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna replication licensing factor mcm3 (dna polymerase alpha holoenzyme-associated protein p1) (rlf beta subunit) (p102 protein) (p1-mcm3). [source:swissprot;acc:p25205]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 233.828\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 231.395\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.433\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein c14orf122 (cgi-112). [source:swissprot;acc:q9y3b6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01164\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1820\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent kelch-like ech-associated protein 1 (cytosolic inhibitor of nrf2). [source:swissprot;acc:q14145]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 233.828\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 231.395\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.433\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 217.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01164\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1821\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l24 (l30). [source:swissprot;acc:p38663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 201.288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 198.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.428\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rna-binding region containing protein 1 (hsrnaseb) (ssdna binding protein seb4) (cll-associated antigen kw-5). [source:swissprot;acc:q9h0z9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01152\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1822\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 240.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 243.085\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01151\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent translation initiation factor eif-2b epsilon subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q13144]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.215\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 224.637\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.422\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1823\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent fragile x mental retardation syndrome related protein 2. [source:swissprot;acc:p51116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 202.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 200.086\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0115\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent translation initiation factor eif-2b gamma subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q9nr50]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.215\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 224.637\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.422\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1824\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent f-actin capping protein alpha-1 subunit (capz alpha-1). [source:swissprot;acc:p52907]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.722\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.281\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0115\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent f-actin capping protein alpha-2 subunit (capz alpha-2). [source:swissprot;acc:p47755]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.746\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.328\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.418\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1825\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna topoisomerase ii, alpha isozyme (ec 5.99.1.3). [source:swissprot;acc:p11388]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 203.759\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 201.349\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.41\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent fragile x mental retardation syndrome related protein 1. [source:swissprot;acc:p51114]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 202.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 200.086\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0115\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1826\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleoporin nup43 (p42). [source:swissprot;acc:q8nfh3]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 202.393\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 200.094\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01149\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent williams-beuren syndrome critical region protein 20 copy b. [source:refseq;acc:nm\_145645]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.862\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 226.271\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 2.409\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1827\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent atp-dependent clp protease atp-binding subunit clpx-like, mitochondrial precursor. [source:swissprot;acc:o76031]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 222.819\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 225.228\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent nucleoside diphosphate kinase 3 (ec 2.7.4.6) (ndk 3) (ndp kinase 3) (nm23-h3) (dr-nm23). [source:swissprot;acc:q13232]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 191.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 189.219\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.01147\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1828\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent fragile x mental retardation 1 protein (protein fmr-1) (fmrp). [source:swissprot;acc:q06787]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 202.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 200.115\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent williams beuren syndrome critical region 20a isoform 2; nol1/nop2/sun gene family member; williams-beuren syndrome critical region protein 20 copy a; williams beuren syndrome chromosome region 20. [source:refseq;acc:nm\_018044]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.862\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 226.271\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 2.409\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1829\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cad protein [includes: glutamine-dependent carbamoyl-phosphate synthase (ec 6.3.5.5); aspartate carbamoyltransferase (ec 2.1.3.2); dihydroorotase (ec 3.5.2.3)]. [source:swissprot;acc:p27708]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.01146\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/